Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bodenmüller H[au]:

Enzyme-linked immunosorbent assay for the neuropeptide 'head activator'. Schaller HC et al. Eur J Biochem. (1984)

Circulating nucleosomes in serum. Holdenrieder S et al. Ann N Y Acad Sci. (2001)

Nucleosomes in serum of patients with benign and malignant diseases. Holdenrieder S et al. Int J Cancer. (2001)

Search results

Items: 35

1.

Towards a comprehensive proteome of normal and malignant human colon tissue by 2-D-LC-ESI-MS and 2-DE proteomics and identification of S100A12 as potential cancer biomarker.

Thierolf M, Hagmann ML, Pfeffer M, Berntenis N, Wild N, Roeßler M, Palme S, Karl J, Bodenmüller H, Rüschoff J, Rossol S, Rohr G, Rösch W, Friess H, Eickhoff A, Jauch KW, Langen H, Zolg W, Tacke M.

Proteomics Clin Appl. 2008 Jan;2(1):11-22. doi: 10.1002/prca.200780046. Epub 2007 Dec 11. No abstract available.

PMID:
21136775
2.

Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.

Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmüller H, Rüschoff J, Henkel T, Rohr G, Rossol S, Rösch W, Langen H, Zolg W, Tacke M.

Mol Cell Proteomics. 2006 Nov;5(11):2092-101. Epub 2006 Aug 6.

3.

Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.

Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, Engel AM, Schneidinger B, Pfeffer M, Andres H, Karl J, Bodenmüller H, Rüschoff J, Henkel T, Rohr G, Rossol S, Rösch W, Langen H, Zolg W, Tacke M.

Clin Cancer Res. 2005 Sep 15;11(18):6550-7.

4.

Circulating nucleosomes in serum.

Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Von Pawel J, Schalhorn A, Nagel D, Seidel D.

Ann N Y Acad Sci. 2001 Sep;945:93-102. Review.

PMID:
11708501
5.

Serum tenascin-C is an indicator of inflammatory bowel disease activity.

Riedl S, Tandara A, Reinshagen M, Hinz U, Faissner A, Bodenmüller H, Buhr HJ, Herfarth C, Möller P.

Int J Colorectal Dis. 2001 Sep;16(5):285-91.

PMID:
11686525
6.

Nucleosomes in serum as a marker for cell death.

Holdenrieder S, Stieber P, Bodenmüller H, Fertig G, Fürst H, Schmeller N, Untch M, Seidel D.

Clin Chem Lab Med. 2001 Jul;39(7):596-605.

PMID:
11522104
7.

Nucleosomes in serum of patients with benign and malignant diseases.

Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Fertig G, Fürst H, Schalhorn A, Schmeller N, Untch M, Seidel D.

Int J Cancer. 2001 Mar 20;95(2):114-20. Erratum in: Int J Cancer 2001 Nov 20;95(6):398.

8.

Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop.

Nap M, van Wel T, Andrés C, Bellanger L, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Meier T, Seguin P, Sjödin A, Stigbrand T, Sundström BE, van Dalen A, Wiebelhaus E, Wiklund B, Hilgers J.

Tumour Biol. 2001 Jan-Feb;22(1):4-10.

PMID:
11054021
9.

Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.

Stigbrand T, Andrés C, Bellanger L, Bishr Omary M, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjödin A, Sundström B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J.

Tumour Biol. 1998;19(2):132-52.

PMID:
9486565
10.

Occult epithelial tumor cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19.

Höchtlen-Vollmar W, Gruber R, Bodenmüller H, Felber E, Lindemann F, Passlick B, Schlimok G, Pantel K, Riethmüller G.

Int J Cancer. 1997 Feb 7;70(4):396-400.

11.

Standards required for quantification of skeletal alkaline phosphatase.

Klein G, Bodenmüller H.

Clin Chem. 1996 Mar;42(3):480-2. No abstract available.

12.

Significance of tenascin serum level as tumor marker in primary colorectal carcinoma.

Riedl S, Bodenmüller H, Hinz U, Holle R, Möller P, Schlag P, Herfarth C, Faissner A.

Int J Cancer. 1995 Feb 20;64(1):65-9.

PMID:
7545144
13.

CYFRA 21-1--clinical applications and analytical requirements.

Ebert W, Bodenmüller H, Hölzel W.

Scand J Clin Lab Invest Suppl. 1995;221:72-80. Review.

PMID:
7544488
14.

The biochemistry of CYFRA 21-1 and other cytokeratin-tests.

Bodenmüller H.

Scand J Clin Lab Invest Suppl. 1995;221:60-6.

PMID:
7544487
15.

Lung cancer-associated keratin 19 fragments: development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1.

Bodenmüller H, Ofenloch-Hähnle B, Lane EB, Dessauer A, Böttger V, Donié F.

Int J Biol Markers. 1994 Apr-Jun;9(2):75-81.

PMID:
7523545
16.

The tumor markers TPA, TPS, TPACYK and CYFRA 21-1 react differently with the keratins 8, 18 and 19.

Bodenmüller H, Donié F, Kaufmann M, Banauch D.

Int J Biol Markers. 1994 Apr-Jun;9(2):70-4.

PMID:
7523544
17.

Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.

Stieber P, Bodenmüller H, Banauch D, Hasholzner U, Dessauer A, Ofenloch-Hähnle B, Jaworek D, Fateh-Moghadam A.

Clin Biochem. 1993 Aug;26(4):301-4.

PMID:
7694815
18.

CYFRA 21-1. A new marker in lung cancer.

Stieber P, Hasholzner U, Bodenmüller H, Nagel D, Sunder-Plassmann L, Dienemann H, Meier W, Fateh-Moghadam A.

Cancer. 1993 Aug 1;72(3):707-13.

PMID:
7687515
19.

Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma.

Rosalki SB, Foo AY, Burlina A, Prellwitz W, Stieber P, Neumeier D, Klein G, Poppe WA, Bodenmüller H.

Clin Chem. 1993 Apr;39(4):648-52.

20.

1H-nuclear magnetic resonance studies of the neuropeptide head activator.

Saffrich R, Kalbitzer HR, Bodenmüller H, Muhn P, Pipkorn R, Schaller HC.

Biochim Biophys Acta. 1989 Jul 27;997(1-2):144-53.

PMID:
2752051
21.

Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumors.

Schaller HC, Schilling E, Theilmann L, Bodenmüller H, Sachsenheimer W.

J Neurooncol. 1988 Nov;6(3):251-8.

PMID:
3225643
22.

Synthesis of new head-activator analogues and their application for improved radioimmunoassays.

Bodenmüller H, Escher E, Zachmann B, Schilling E.

Int J Pept Protein Res. 1987 Jan;29(1):140-4.

PMID:
3570652
23.

The head activator is released from regenerating Hydra bound to a carrier molecule.

Schaller HC, Roberge M, Zachmann B, Hoffmeister S, Schilling E, Bodenmüller H.

EMBO J. 1986 Aug;5(8):1821-4.

24.

The neuropeptide head activator loses its biological acitivity by dimerization.

Bodenmüller H, Schilling E, Zachmann B, Schaller HC.

EMBO J. 1986 Aug;5(8):1825-9.

25.

Ninth Adolf Butenandt lecture. Role of the neuropeptide head activator for nerve function and development.

Schaller HC, Bodenmüller H.

Biol Chem Hoppe Seyler. 1985 Nov;366(11):1003-7. Review. No abstract available.

PMID:
3907660
26.

The head activator: discovery, characterisation, immunoassays and biological properties in mammals.

Bodenmüller H, Roberge M.

Biochim Biophys Acta. 1985 Jul 24;825(3):261-7. Review. No abstract available.

PMID:
2410027
27.
28.

Enzyme-linked immunosorbent assay for the neuropeptide 'head activator'.

Schaller HC, Bodenmüller H, Zachmann B, Schilling E.

Eur J Biochem. 1984 Jan 16;138(2):365-71.

29.

The neuropeptide head activator stimulates amylase release from rat pancreas in vitro.

Feurle GE, Bodenmüller H, Baća I.

Neurosci Lett. 1983 Aug 8;38(3):287-9.

PMID:
6195558
30.

Isolation and amino acid sequence of a morphogenetic peptide from hydra.

Schaller HC, Bodenmüller H.

Proc Natl Acad Sci U S A. 1981 Nov;78(11):7000-4.

31.

Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans.

Bodenmüller H, Schaller HC.

Nature. 1981 Oct 15-21;293(5833):579-80. No abstract available.

PMID:
7290191
32.

Synthesis of a new neuropeptide, the head activator from hydra.

Birr C, Zachmann B, Bodenmüller H, Schaller HC.

FEBS Lett. 1981 Aug 31;131(2):317-21. No abstract available.

33.

Virotoxins: actin-binding cyclic peptides of Amanita virosa mushrooms.

Faulstich H, Buku A, Bodenmüller H, Wieland T.

Biochemistry. 1980 Jul 8;19(14):3334-43.

PMID:
6893271
34.

Amaninamide, a new toxin of Amanita virosa mushrooms.

Buku A, Wieland T, Bodenmüller H, Faulstich H.

Experientia. 1980 Jan 15;36(1):33-4.

PMID:
7188908
35.

Human hypothalamus and intestine contain a hydra-neuropeptide.

Bodenmüller H, Schaller HC, Darai G.

Neurosci Lett. 1980 Jan;16(1):71-4.

PMID:
7052424

Supplemental Content

Loading ...
Support Center